Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Muscle Damage clinical trials

3 of 7 indexed Muscle Damage trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Muscle Damage: 7 US clinical trials tracked, 3 recruiting.

Muscle Damage is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Metabolic Technologies, running 1 of these trials.

Enrollment posture brief

Registry condition muscle-damage

OPEN 3 | RECR 43% | LATE 0 | EARLY 0 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Muscle Damage (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Muscle Damage

Muscle Damage lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Muscle Damage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Muscle Damage is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Muscle Damage trials is spread across many organizations.

    Metabolic Technologies accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Muscle Damage trials plan to enrol fewer than 100 people.

    Median target enrolment is 33 among the 7 trials that report a genuine target (sentinel values excluded). 7 of those (100%) plan for fewer than 100 participants.

  4. Muscle Damage research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Muscle Damage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Dietary supplement
3 trials
Oceanix Dietary supplement
1 trials
beta-hydroxy-beta-methylbutyrate free acid (HMB-FA) Dietary supplement
1 trials
cold water immersion Procedure
1 trials
Protein supplement Dietary supplement
1 trials
Treatment with BTL-899M with intensities below therapeutic threshold Device
1 trials
Treatment with BTL-899M Device
1 trials
Solarplast (R) Dietary supplement
1 trials

US sites by state

Facility locations filed on Muscle Damage trials. A trial with sites in several states counts in each.

Florida 4 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials
Colorado 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Muscle Damage page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Muscle Damage condition card totals 7 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.